EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for CTEV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -3.491
March 31, 2026 -4.407
December 31, 2025 -4.875
September 30, 2025 -4.232
June 30, 2025 -3.807
March 31, 2025 -4.382
December 31, 2024 -8.523
September 30, 2024 -24.25
June 30, 2024 -35.78
March 31, 2024 -33.40
December 31, 2023 -1.937
September 30, 2023 -1.494
June 30, 2023 -0.0565
March 31, 2023 0.0003
Date Value
December 31, 2022 -40.69
September 30, 2022 0.0308
June 30, 2022 0.0211
March 31, 2022 0.0688
December 31, 2021 1.563
September 30, 2021 0.1198
June 30, 2021 -0.0716
March 31, 2021 0.07
December 31, 2020 -10.58
September 30, 2020 -27.75
June 30, 2020 -5.412
March 31, 2020 -0.2496
December 31, 2019 -0.0004

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.0004
SCWorx Corp. -1.355
Health Catalyst, Inc. -0.5481
GoodRx Holdings, Inc. 0.0245
iSpecimen, Inc. -0.9773